Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.34 |
| ▸ | CA1 | P00915 | 4/20 | 0.34 |
| ▸ | MMP1 | P03956 | 2/20 | 0.34 |
| ▸ | MMP2 | P08253 | 2/20 | 0.34 |
| ▸ | MMP9 | P14780 | 2/20 | 0.34 |
| ▸ | MMP8 | P22894 | 2/20 | 0.34 |
| ▸ | MMP13 | P45452 | 2/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4623340 | 0.85 | KCNH2 (0.45) | KCNH2 | |
| SCHEMBL15670825 | 0.83 | ACHE (0.54) | KCNH2 | |
| Cetylpyridinium SCHEMBL4624903 | 0.83 | ACHE (0.54) | KCNH2 | |
| SCHEMBL30081384 | 0.83 | GGPS1 (0.36) | KCNH2 | |
| SCHEMBL3312380 | 0.83 | GGPS1 (0.36) | KCNH2 | |
| Trifluoromethanesulfonic Acid SCHEMBL1330325 | 0.83 | KCNH2 (0.41) | KCNH2 | |
| Cetylpyridinium SCHEMBL4624474 | 0.82 | ACHE (0.53) | KCNH2 | |
| SCHEMBL4292521 | 0.81 | CA2 (0.37) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL4288346 | 0.80 | CA2 (0.39) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL15993134 | 0.78 | GGPS1 (0.37) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150291515-A1 | SALTS CONTAINING TRIHYDROPERFLUOROALKOXYBUTANESULFONATE OR TRIHYDROPERFLUOROALKOXYPROPANESULFONATE ANION | MERCK PATENT GMBH (DE) | 2015-10-15 | — | — | US | disclosed |
| EP-2914578-A1 | SALTS WITH TRIHYDROPERFLUOROALKOXYBUTANE SULFONATE OR TRIHYDROPERFLUOROALKOXYPROPANE SULFONATE ANION | Merck Patent GmbH (DE) | 2015-09-09 | — | — | EP | disclosed |
| WO-2014067603-A1 | SALTS WITH TRIHYDROPERFLUOROALKOXYBUTANE SULFONATE OR TRIHYDROPERFLUOROALKOXYPROPANE SULFONATE ANION | MERCK PATENT GMBH (DE) | 2014-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291515-A1 | SALTS CONTAINING TRIHYDROPERFLUOROALKOXYBUTANESULFONATE OR TRIHYDROPERFLUOROALKOXYPROPANESULFONATE ANION | STS, ARSA, TST | CA2 446/4885CA1 651/4885MMP1 3091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.